Radiation treatment for patients with intermediate-risk prostate cancer.

about

Radiation treatment for patients with intermediate-risk prostate cancer.

Item

http://www.wikidata.org/entity/Q35992830

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Radiation treatment for patients with intermediate-risk prostate cancer.

@ast

Radiation treatment for patients with intermediate-risk prostate cancer.

@en

type

Item

label

Radiation treatment for patients with intermediate-risk prostate cancer.

@ast

Radiation treatment for patients with intermediate-risk prostate cancer.

@en

prefLabel

Radiation treatment for patients with intermediate-risk prostate cancer.

@ast

Radiation treatment for patients with intermediate-risk prostate cancer.

@en

P1476

Radiation treatment for patients with intermediate-risk prostate cancer.

@en

P2093

David E Greene

http://www.w3.org/2001/XMLSchema#string

Jyoti S Mayadev

http://www.w3.org/2001/XMLSchema#string

Richard K Valicenti

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.

Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.

CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance.

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial.

Complications following permanent prostate brachytherapy.

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer

P304

113-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756287212442977

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225087163

http://www.w3.org/2001/XMLSchema#string

P698

22654963

http://www.w3.org/2001/XMLSchema#string

P932

3361750

http://www.w3.org/2001/XMLSchema#string